American Century Companies
NVLN

American Century Companies’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

American Century Companies’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-22,291
Closed -$70K – 1382
2017
Q4 		$70K Buy
+22,291
New +$107K ﹤0.01% 1256

Other funds holding NVLN

EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

American Century Companies's NVLN Position: Q1 2018 in Review

American Century Companies sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q1 2018, closing a stake of 22,291 shares — an estimated $70K sold.

American Century Companies first reported a position in NVLN in Q4 2017 and held it in 1 quarter. The position peaked at $70K in Q4 2017. 68 funds tracked by Wall St. Rank hold NVLN as of Q1 2018.

  • American Century Companies reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q1 2018 after selling out during the quarter.
  • American Century Companies sold 22,291 Novelion Therapeutics Inc. Common Shares shares in Q1 2018, an estimated $70K.
  • American Century Companies first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2017 and held it in 1 quarter.
  • American Century Companies's Novelion Therapeutics Inc. Common Shares position peaked at $70K in Q4 2017.
  • 68 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q1 2018.

Based on American Century Companies's 13F filing for Q1 2018, filed 3 May 2018.